معرفی
Alexander Ghincea is a Pulmonary, Critical Care & Sleep Medicine Instructor at Yale School of Medicine. He holds primary affiliation with the Department of Pulmonary, Critical Care & Sleep Medicine and is also part of the Internal Medicine department. Previously, he earned his B.S. in Molecular and Cellular Biology from Regis University, completed medical school at the University of Colorado, and served as Chief Resident in Internal Medicine there. His research focuses on pulmonary fibrosis mechanisms, translational models for interstitial lung diseases, mitochondrial DNA-sensing pathways in systemic sclerosis, adrenoreceptor pharmacology, and comorbidities influencing asthma outcomes. Key collaborators include Wonnie Ryu, Erica Herzog, Huanxing Sun, and Maor Sauler.
His work spans experimental mouse models to clinical patient studies, with a recent emphasis on mitigating fibrotic responses through pharmacological interventions (e.g., α1 adrenoreceptor antagonism) and investigating vaccine-related risks in pulmonary diseases. He has published extensively on topics such as CGAS antagonism, NLRP3 inflammasome targeting, and GERD-asthma interactions in obese populations. Though no scientific awards are explicitly listed, his contributions reflect active engagement in high-impact translational research.
Advising roles and formal grants are not detailed in the provided texts, but his involvement in collaborative projects suggests active mentorship within research teams. His academic trajectory aligns with the Yale School of Medicine’s emphasis on integrating clinical and basic science research.